WebAug 1, 2013 · PLATO trial was almost half the duration with a mean follow-up of 277 days compared to TRILOGY ACS (513 days). Matching prorated over follow-up duration of … Web臨床試驗計畫 - |臨床試驗中心|台灣臨床試驗|藥物臨床試驗|醫療器材臨床試驗|臨床研究|GCP教育訓練|本醫院為配合政府全面推動生物科技製藥產業發展進步,加強提昇執行新藥臨床試驗能力與品質,使國人能
Prasugrel versus Clopidogrel for Acute Coronary …
WebThe ATLAS ACS 2 TIMI 51 trial was designed to assess the effect of rivaroxaban, an oral, direct factor Xa inhibitor, in the prevention of further ischemic events when combined with DAPT in patients stabilized after an ACS event. 24 The findings of the trial (efficacy results summarized in Figure 2) led to the European approval of rivaroxaban 2.5 mg twice daily in … WebApr 13, 2024 · The Augustus trial previously reported the benefit of apixaban instead of vitamin-K antagonist (VKA) and ongoing P2Y12i monotherapy rather than DAPT for patients with AF and ACS/PCI . Harskamp et al. undertook a new analysis of 4,386 patients from Augustus to assess if benefits varied depending on baseline HASBLED (≤ 2 vs. ≥ 3) and … the hut 20%
Learn the Heart - Healio
WebTRILOGY ACS, said Professor Ohman, was designed as a follow-up to the TRITON trial, "to see if prasugrel was just as effective in ACS patients who aren't getting coronary stents or … WebAims: Little is known regarding consequences of frailty in patients with acute coronary syndrome (ACS). We assessed the associations of frailty and outcomes in ACS patients … WebLearn the Heart - Healio the hustyns wadebridge